DCGI's subject expert committee to hold discussion on 'Five Arms' intranasal heterologous booster dose on Nov 15, sources

Nov 12, 2022

DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in September this year applied for DCGI's approval...

DCGI approves '5-arms intranasal hetrologous booster dose' for restricted use

Nov 25, 2022

The Drugs Controller General of India (DCGI) has given approval to intranasal "Five Arms" booster dose for restricted use for COVID-19 patients, it is...

Bharat Biotech applies for market authorisation from DCGI for five arms intranasal heterologous booster

Sep 11, 2022

New Delhi [India], September 11 : Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous...

Bharat Biotech's intranasal heterologous booster dose likely to hit market in February first week

Jan 23, 2023

According to the company, the price of iNCOVACC will be Rs 900 for the private market and Rs 325 for supplies to the Government...

DCGI recommends Covovax as heterologous booster dose

Jan 12, 2023

The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as...

Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID booster intranasal vaccine

Jan 05, 2022

New Delhi [India], January 5 : The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to...